Study Finds People with Certain Blood Types Have Increased Risks of Heart Attack During Periods of High Air Pollution
Individuals who have A, B, or AB blood types have an elevated risk of having a heart attack during periods of significant air pollution, compared to those with the O blood type, according to a new study from the Intermountain Medical Center Heart...
9-Nov-2017 10:15 AM EST Add to Favorites
Many Hospitalized Heart Patients Discharged Not Getting Protective Statin Medications Upon Release, Fewer Remaining on Medicine After One Year
While patients who are discharged from the hospital after treatment for heart disease, cerebrovascular disease, or peripheral artery disease, should be on statin medications to reduce their risk of reoccurrence, very few of them remain on the drugs...
10-Nov-2017 10:00 AM EST Add to Favorites
Extreme ups and downs in systolic blood pressure may be just as deadly as having consistently high blood pressure, according to a new study from the Intermountain Medical Center Heart Institute in Salt Lake City.
9-Nov-2017 5:00 AM EST Add to Favorites
Reduction in Common Heart Hormone Associated with Improved Outcomes and Lower Mortality for Heart Failure Patients
Heart failure patients discharged from the hospital with a reduced level of a common hormone produced by the heart had significantly lower rates of readmission and lower death rates.
8-Nov-2017 8:30 AM EST Add to Favorites
If you have a heart attack or stroke, it’s important to get your “bad” cholesterol measured by your doctor on a follow up visit. Researchers have found that one step is significantly associated with a reduced risk of suffering another serious...
8-Nov-2017 12:00 PM EST Add to Favorites
Heart Attack, Stroke Patients Prescribed Statin Medication Upon Discharge Have Better Long-Term Outcomes
Patients with a prior history of heart attacks or stroke have better outcomes when cholesterol-lowering medications are used after they’re discharged from the hospital, according to a new study from the Intermountain Medical Center Heart Institute...
8-Nov-2017 3:00 PM EST Add to Favorites
Genetic Testing Can Help Determine Safest Dose of Blood Thinner for Joint Surgery Patients, Study Shows
A new five-year study of nearly 1,600 patients finds that genetic testing can help determine the safest dose of the blood thinner warfarin, with fewer side effects, in patients undergoing joint replacement surgery.
23-Oct-2017 5:00 AM EDT Add to Favorites
Goal of new Intermountain Healthcare genomics study is to show whether screening patients for the presence of circulating tumor DNA, known as ctDNA, can successfully detect breast cancer using a blood draw.
11-Oct-2017 5:00 AM EDT Add to Favorites
28-Mar-2014 9:00 AM EDT